Rifaximin EP Impurity B

SZ目录编号:	SZ-R027003
CAS 号	13929-35-6
分子式	C39H49NO14
分子量	755.8
投资状态	In Stock

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.

化学名称: 4-O-(Carboxymethyl)rifamycin

异名: Rifamycin B

Shipping Temperature: Ambient

HSN Code: 38229010

Country of Origin: India

微笑: [H][C@@](OC(C)=O)([C@@H]([C@H](/C=C/O[C@]1(OC2=C(C(O)=C3C4=C2C1=O)C)C)OC)C)[C@H](C)[C@@H]([C@@H]([C@H]([C@H](/C=C/C=C(C(NC(C=C4OCC(O)=O)=C3O)=O)/C)C)O)C)O

Structural elucidation of the Rifaximin Ph. Eur. Impurity H
Riccardo Stradi, Donatella Nava, Marino Nebuloni, Barbara Pastura, ElenaPini
Journal of Pharmaceutical and Biomedical Analysis Volume 51, Issue 4, 11 March 2010, Pages 858-865

Structure Elucidation of Two Unknown Oxydic Degradation Impurities of Rifaximin
chao liu, chang-qin hu and shao-hong jin
Asian Journal of Chemistry; Vol. 23, No. 7 (2011), 3252-3256

Development and validation of rp-hplc method for the estimation of rifaximin in bulk and in tablet dosage form
T.sudha, P.V.hemalatha, V.R.ravikumar,r.jothi, M.radhakrishnan
Asian Journal of Pharmaceutical and Clinical Research Vol.2 Issue 4, October-December 2009

Stability Indicating HPTLC Method for Analysis of Rifaximin in Pharmaceutical Formulations and an Application to Acidic Degradation Kinetic Study
Kalpana G. Patel , Nitesh R. Jain, and Purvi A. Shah
Hindawi Publishing Corporation ISRN Analytical Chemistry Volume 2013, Article ID 613218, 9 pages

Rifaximin EP Impurity B is chemically 4-O-(Carboxymethyl)rifamycin . It is also known as Rifamycin B. Rifaximin EP Impurity B is supplied with detailed characterization data compliant with regulatory guideline. Rifaximin EP Impurity B can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rifaximin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

SZ目录编号:	: SZ-R027004
CAS 号	: 14897-39-3
分子式	: C37H46NO12 : Na
分子量	: 696.8 : 23.0
投资状态	: In Stock
Rel. CAS No	: 6998-60-3 (free base)
Rel. CAT No	: SZ-R058001 ,

SZ目录编号:	: SZ-R027006
CAS 号	: 13553-79-2
分子式	: C37H45NO12
分子量	: 695.8
投资状态	: In Stock
Rel. CAS No	: 133956-65-7 (sodium salt)
Rel. CAT No	: SZ-R058003 ,

SZ目录编号:	: SZ-R027007
CAS 号	: 14487-05-9
分子式	: C39H47NO14
分子量	: 753.8
投资状态	: In Stock
Rel. CAT No	: SZ-R058004 ,

Rifaximin EP Impurity B

Contacts

Our Locations

SZ目录编号:	: SZ-R027001
CAS 号	: 80621-81-4
分子式	: C43H51N3O11
分子量	: 785.9
投资状态	: In Stock

SZ目录编号:	: SZ-R027002
CAS 号	: 695-34-1
分子式	: C6H8N2
分子量	: 108.1
投资状态	: In Stock

SZ目录编号:	: SZ-R027003
CAS 号	: 13929-35-6
分子式	: C39H49NO14
分子量	: 755.8
投资状态	: In Stock
Rel. CAT No	: SZ-R058002 ,

SZ目录编号:	: SZ-R027005
CAS 号	: NA
分子式	: C43H49N3O12
分子量	: 799.9
投资状态	: Custom Synthesis

SZ目录编号:	: SZ-R027008
CAS 号	: 80621-76-7
分子式	: C43H49N3O11
分子量	: 783.9
投资状态	: In Stock

SZ目录编号:	: SZ-R027009
CAS 号	: 1210022-90-4
分子式	: C43H51N3O12
分子量	: 801.9
投资状态	: Custom Synthesis

SZ目录编号:	: SZ-R027010
CAS 号	: 1351775-04-6
分子式	: C43H49N3O11
分子量	: 783.9
投资状态	: In Stock

SZ目录编号:	: SZ-R027011
CAS 号	: 1351775-03-5
分子式	: C43H49N3O11
分子量	: 783.9
投资状态	: In Stock

SZ目录编号:	: SZ-R027012
CAS 号	: 16783-99-6
分子式	: C41H56N4O11
分子量	: 780.9
投资状态	: In Stock

SZ目录编号:	: SZ-R027013
CAS 号	: NA
分子式	: C44H60N4O11
分子量	: 821.0
投资状态	: Custom Synthesis

SZ目录编号:	: SZ-R027014
CAS 号	: 80621-88-1
分子式	: C41H49N3O10
分子量	: 743.9
投资状态	: In Stock

SZ目录编号:	: SZ-R027D01
CAS 号	: 1262992-43-7
分子式	: C43H45D6N3O11
分子量	: 791.9
投资状态	: Custom Synthesis

SZ目录编号:	: SZ-R027015
CAS 号	: NA
分子式	: C43H49N3O12 : C43H51N3O12
分子量	: 799.9 : 801.9
投资状态	: Custom Synthesis